PHT Corp, a company that deals with electronic data for clinical research, has made the move to Windows 8.1 with the Dell Venue 11 Pro tablets. The company has gone paperless and chose the Dell tablet powered by Microsoft’s latest operating system due to its “superior user experience.”
“PHT Corporation, the leading provider of technologies used to collect patient-driven electronic data for clinical research, has selected Dell Venue 11 Pro tablets featuring Windows 8.1 to run its SitePad System. The SitePad System replaces traditional paper data collection methods in clinical research with electronic methods, providing better-quality data, real-time access to that data and, ultimately, faster time to data analysis for pharmaceutical trial sponsors. The SitePad System is used in clinical trials to collect clinician- and patient-reported outcomes for supporting label claims of new therapies,” Microsoft stated in an official blog post today.
PHT selected the Windows 8.1 tablet due to its flexibility, security, and the quality of realtime site-based data capture for trial participants and clinicians. PHT can run custom software on the tablet to decrease clinical trial costs and more. PHT touts the Dell Venue 11 Pro and Windows 8.1 experience as comfortable and convenient, allowing rapid entry of clinical data.
“The Dell Venue 11 Pro with Windows 8.1 is a modern and sleek device that both patients and clinicians enjoy using – the usability testing feedback has been excellent,” Sheila Rocchio said. She is the vice president of Marketing & Product Management at PHT. “Sponsors are also very excited about the embedded 4G modem in the Dell Venue 11 Pro, which eliminates the need for an additional wireless hotspot, making setup much easier.”
PHT has purchased more than 2,000 Dell Venue 11 Pros and will deploy them at clinical trial sites worldwide.
